Samuel John

1 Patent

• US125707102026

  Targeting LILRB4 with CAR-T or CAR-NK Cells in the Treatment of Cancer

  THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM

  0 cites